Next Gen Diagnostics Announces that Dr. Tony Cox, Director of Advanced Sequencing Pipeline Research at the Wellcome Sanger Institute, Has Joined its Scientific Advisory Board

PRESS RELEASE
Written By Casey-Drew Williams

Next Gen Diagnostics is pleased to announce that Dr. Tony Cox, Head of DNA Pipelines Development at the Wellcome Sanger Institute, has joined its Scientific Advisory Board.  Dr. Cox is Group Leader of both DNA Pipeline Informatics as well as DNA Pipelines Research and Development, and as such has very broad experience, at industrial scale, with the very highest quality and highest volume sample preparation, sequencing, bioinformatics pipeline in the world. 

Casey-Drew Williams
Previous

Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
Next

Next Gen Diagnostics Selected to Partner with a UK Consortium To Conduct The First Trial Of Prospective Sequencing-Enabled Transmission Detection, At Addenbrooke’s Hospital, In Cambridge, UK.